Subscribe
Sign in
Home
Notes
Archive
Leaderboard
About
Latest
Top
The Gut Punch Weekly #29
Medicare plans trial coverage for obesity drugs, GLP-1 opportunities amid foodtech slump, Novo continues taking L's, Lilly's new oral GLP-1 is pretty…
Aug 13
1
Share this post
The Gut Punch
The Gut Punch Weekly #29
Copy link
Facebook
Email
Notes
More
July 2025
The Gut Punch Weekly #28
GLP-1s could become the "everything drug", Novo stock plummets 20%, Trump's tariff on European drugs may raise prices, and more!
Jul 30
Share this post
The Gut Punch
The Gut Punch Weekly #28
Copy link
Facebook
Email
Notes
More
The Gut Punch Weekly #27
The hidden protein opportunity, Ozempic may treat addiction cravings, Hengrui's new drug achieves 18% weight loss, Hims is the king of knockoff Ozempic…
Jul 16
Share this post
The Gut Punch
The Gut Punch Weekly #27
Copy link
Facebook
Email
Notes
More
The Gut Punch Weekly #26
Lilly's antibody preserves muscle, Novo Nordisk ends Hims deal, China approves first dual GLP-1/GCG obesity drug, and more!
Jul 2
1
Share this post
The Gut Punch
The Gut Punch Weekly #26
Copy link
Facebook
Email
Notes
More
June 2025
The Gut Punch Weekly #25
Lilly's Amylin drug shows weight loss with fewer side effects, Novo Nordisk loses Canadian Ozempic patent over unpaid $250 fee, and more!
Jun 18
1
Share this post
The Gut Punch
The Gut Punch Weekly #25
Copy link
Facebook
Email
Notes
More
The Gut Punch Weekly #24
GLP-1s elevate eye disease risk, Lilly and Camurus partner on long-acting obesity drugs, GLP-1s linked to unexpected pregnancies, and more!
Jun 11
2
Share this post
The Gut Punch
The Gut Punch Weekly #24
Copy link
Facebook
Email
Notes
More
The Gut Punch Weekly #23
Production missteps ended Novo Nordisk's dominance, Regeneron secures $2B deal for Hansoh's obesity drug, Regeneron drug combo preserves muscle mass…
Jun 4
1
Share this post
The Gut Punch
The Gut Punch Weekly #23
Copy link
Facebook
Email
Notes
More
May 2025
The Gut Punch Weekly #22
MAHA report calls for broad food & health shakeup, Doctors See Broad Medical Uses for GLP-1s, Wegovy Offers Limited $199 Deal, and more!
May 28
Share this post
The Gut Punch
The Gut Punch Weekly #22
Copy link
Facebook
Email
Notes
More
The Gut Punch Weekly #21
Novo's CEO gets the boot, compounders exploit a loophole to keep selling GLP-1 knockoffs, a conversation with the founder of SuperGut, and more!
May 21
Share this post
The Gut Punch
The Gut Punch Weekly #21
Copy link
Facebook
Email
Notes
More
The Gut Punch Weekly #20
Trump targets high prices of GLP-1s, Zepbound outperforms Wegovy in weight loss, WeightWatchers files for bankruptcy, weight loss drugs alter taste for…
May 14
Share this post
The Gut Punch
The Gut Punch Weekly #20
Copy link
Facebook
Email
Notes
More
The Gut Punch Weekly #19
Wegovy shows promise in treating liver disease, Novo secures preferred spot on CVS formulary, WHO endorses weight-loss drugs, and more!
May 7
Share this post
The Gut Punch
The Gut Punch Weekly #19
Copy link
Facebook
Email
Notes
More
April 2025
The Gut Punch Weekly #18
Novo declares truce with telehealth cos, GLP-1 compounders keep losing in court, poultry intake linked to significantly higher early death risk, and…
Apr 30
Share this post
The Gut Punch
The Gut Punch Weekly #18
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts